Sanofi

Sanofi is an R&D-driven, AI-powered biopharmaceutical company developing medicines and vaccines across five core therapeutic areas: immunology, neurology, oncology, rare diseases and vaccines. Its pipeline comprises 80 compounds in clinical development, 28 of them in phase 3 trials. The company applies immune system expertise and artificial intelligence across the R&D value chain, from drug discovery and clinical development to vaccine development and the digitalisation of research processes.

Employment at Sanofi spans more than 70 countries and a workforce of over 100,000 people, known internally as Sanofians, working across laboratories, field teams and corporate functions in multiple time zones. Technical work covers AI-powered R&D, immunology, drug discovery, clinical development and vaccine research, with roles distributed across the five therapeutic areas.

The company describes its purpose as chasing the miracles of science to improve people's lives. Its stated culture emphasises collaboration, curiosity and a persistent pursuit of scientific progress, alongside commitments to diversity and inclusion, sustainability and employee wellbeing. Sanofi states an aim of building growth while acting responsibly towards patients, the planet and its employees.